Literature DB >> 12716038

Colorectal carcinoma in black and white race.

William F Anderson1, Asad Umar, Otis W Brawley.   

Abstract

Worldwide, colorectal carcinoma (CRC) varies by race-ethnicity. The highest incidence occurs in whites of European descent. Rates in blacks of South Africa are much lower, but rise with migration to westernized countries, i.e. African Americans (blacks) in the US. In the US, CRC age-specific incidence rates increased dramatically with biologic aging for black and white men and women. For all ages, rates were slightly higher for black than for whites. Among whites, overall annual rates peaked in the 1980s then declined. Stage- and subsite-specific rate shifts suggested earlier detection of cancers through screening, particularly in the distal colon. Blacks have not experienced the same stage- and subsite temporal shifts, which were observed in whites. CRC racial differences have been attributed to biologic and/or non-biologic factors as well as to routine screening patterns. Racial variations demonstrate the need for a more comprehensive understanding of colorectal carcinogenesis, epidemiology, and colorectal screening patterns for low- and high-risk populations.

Entities:  

Mesh:

Year:  2003        PMID: 12716038     DOI: 10.1023/a:1022264002228

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  24 in total

1.  Telephone outreach to increase colorectal cancer screening in an urban minority population.

Authors:  Charles E Basch; Randi L Wolf; Corey H Brouse; Celia Shmukler; Alfred Neugut; Lawrence T DeCarlo; Steven Shea
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

2.  Colorectal cancer screening awareness and intentions among low income, sociodemographically diverse adults under age 50.

Authors:  Karen Emmons; Elaine Puleo; Lorna H McNeill; Gary Bennett; Sophia Chan; Sapna Syngal
Journal:  Cancer Causes Control       Date:  2008-05-14       Impact factor: 2.506

3.  MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)--description of four novel mutations.

Authors:  Alejandro Giraldo; Andrea Gómez; Gustavo Salguero; Herbert García; Fabio Aristizábal; Oscar Gutiérrez; Luis Alberto Angel; Jorge Padrón; Carlos Martínez; Humberto Martínez; Omar Malaver; Luis Flórez; Rosa Barvo
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Metformin efficacy and safety for colorectal polyps: a double-blind randomized controlled trial.

Authors:  Takuma Higurashi; Hirokazu Takahashi; Hiroki Endo; Kunihiro Hosono; Eiji Yamada; Hidenori Ohkubo; Eiji Sakai; Takashi Uchiyama; Yasuo Hata; Nobutaka Fujisawa; Shiori Uchiyama; Akiko Ezuka; Hajime Nagase; Takaomi Kessoku; Nobuyuki Matsuhashi; Shoji Yamanaka; Yoshiaki Inayama; Satoshi Morita; Atsushi Nakajima
Journal:  BMC Cancer       Date:  2012-03-26       Impact factor: 4.430

5.  Is proliferative colonic disease presentation changing?

Authors:  Vito D Corleto; Cristiano Pagnini; Maria Sofia Cattaruzza; Ermira Zykaj; Emilio Di Giulio; Giovanna Margagnoni; Emanuela Pilozzi; Giancarlo D'Ambra; Antonietta Lamazza; Enrico Fiori; Mario Ferri; Luigi Masoni; Vincenzo Ziparo; Bruno Annibale; Gianfranco Delle Fave
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

6.  Relationship of human rectal aberrant crypt foci and formation of colorectal polyp: One-year following up after polypectomy.

Authors:  Hirokazu Takahashi; Eiji Yamada; Hidenori Ohkubo; Eiji Sakai; Takuma Higurashi; Takashi Uchiyama; Kunihiro Hosono; Hiroki Endo; Atsushi Nakajima
Journal:  World J Gastrointest Endosc       Date:  2012-12-16

7.  NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect?

Authors:  Elizabeth B Lamont; Lauren E Dias; Diane S Lauderdale
Journal:  J Gen Intern Med       Date:  2007-06-19       Impact factor: 5.128

8.  Visual distraction alone for the improvement of colonoscopy-related pain and satisfaction.

Authors:  Shotaro Umezawa; Takuma Higurashi; Shiori Uchiyama; Eiji Sakai; Hidenori Ohkubo; Hiroki Endo; Takashi Nonaka; Atsushi Nakajima
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  PPARgamma Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study.

Authors:  Hirokazu Takahashi; Kunihiro Hosono; Takashi Uchiyama; Michiko Sugiyama; Eiji Sakai; Hiroki Endo; Shin Maeda; Katherine L Schaefer; Hitoshi Nakagama; Atsushi Nakajima
Journal:  PPAR Res       Date:  2010-08-02       Impact factor: 4.964

10.  Association of the DNMT3A -448A>G polymorphism with genetic susceptibility to colorectal cancer.

Authors:  Zhujiang Zhao; Can Li; Yunwei Song; Qunying Wu; Fengchang Qiao; Hong Fan
Journal:  Oncol Lett       Date:  2011-11-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.